Java Med ApS: Financial statements 2025
CVR: 43919881
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Java Med ApS (CVR 43919881) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 63,216 and a net result of DKK 58,913 compared with DKK -29,456 the year before. Equity in the 2025 report amounted to DKK 53,793. The solvency ratio was 26.6%.
- Gross Profit
- DKK 63,216
- Profit/Loss
- DKK 58,913
- Equity
- DKK 53,793
- Total Assets
- DKK 202,266
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 63 t. | 59 t. | 54 t. | 0 |
| 2024 | - | -29 t. | -29 t. | -5 t. | - |
How creditworthy is Java Med ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Java Med ApS has published its annual report for 2024. Gross profit came to DKK -29,478, and the net result was DKK -29,456.
About Java Med ApS
Java Med ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anni Søgaard. The company is owned by Søgaard DK Holding ApS. In 2025, the company reported a gross profit of DKK 63,216 and a net result of DKK 58,913 compared with DKK -29,456 the year before. Equity in the 2025 report amounted to DKK 53,793.